Cite
HARVARD Citation
Fasslrinner, F. et al. (2019). Midostaurin abrogates CD33‐directed UniCAR and CD33‐CD3 bispecific antibody therapy in acute myeloid leukaemia. British journal of haematology. pp. 735-740. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fasslrinner, F. et al. (2019). Midostaurin abrogates CD33‐directed UniCAR and CD33‐CD3 bispecific antibody therapy in acute myeloid leukaemia. British journal of haematology. pp. 735-740. [Online].